Varicella in day care centers.

P. A. Brunell, Jean A Wiedeman, A. W. Lievens

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Spread of varicella in day care is controlled by excluding children at the first signs of illness. Exclusion is generally ineffective. Minimally ill children might be permitted to attend day care. This approach may lead to exposure of those in high-risk groups, i.e., adults or immunocompromised children. Morbidity is greater in adults, but susceptibility among day care workers is probably low. Immunocompromised children can be vaccinated or given varicella-zoster immune globulin (VZIG) after exposure. Questions about the risks of varicella-zoster vaccination (V-Z) concern the production of latent infection and subsequent zoster and the effect on the epidemiology of infection, i.e., its possible delay until adulthood. Zoster has been found not to be more frequent in immunized than in nonimmunized leukemic children, and normal vaccinees retain good antibody titers five years after vaccination and have titers similar to individuals who have had varicella 10 years after vaccination. Vaccine efficacy is excellent, but its desirability will be determined after resolution of questions concerning the long-term impact of its use.

Original languageEnglish (US)
Pages (from-to)589-590
Number of pages2
JournalReviews of Infectious Diseases
Volume8
Issue number4
StatePublished - Jul 1986
Externally publishedYes

Fingerprint

Chickenpox
Herpes Zoster
Vaccination
Infection
Epidemiology
Vaccines
Morbidity
Antibodies

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Brunell, P. A., Wiedeman, J. A., & Lievens, A. W. (1986). Varicella in day care centers. Reviews of Infectious Diseases, 8(4), 589-590.

Varicella in day care centers. / Brunell, P. A.; Wiedeman, Jean A; Lievens, A. W.

In: Reviews of Infectious Diseases, Vol. 8, No. 4, 07.1986, p. 589-590.

Research output: Contribution to journalArticle

Brunell, PA, Wiedeman, JA & Lievens, AW 1986, 'Varicella in day care centers.', Reviews of Infectious Diseases, vol. 8, no. 4, pp. 589-590.
Brunell PA, Wiedeman JA, Lievens AW. Varicella in day care centers. Reviews of Infectious Diseases. 1986 Jul;8(4):589-590.
Brunell, P. A. ; Wiedeman, Jean A ; Lievens, A. W. / Varicella in day care centers. In: Reviews of Infectious Diseases. 1986 ; Vol. 8, No. 4. pp. 589-590.
@article{0e4062e55e9340af9b92820f5a2b05e8,
title = "Varicella in day care centers.",
abstract = "Spread of varicella in day care is controlled by excluding children at the first signs of illness. Exclusion is generally ineffective. Minimally ill children might be permitted to attend day care. This approach may lead to exposure of those in high-risk groups, i.e., adults or immunocompromised children. Morbidity is greater in adults, but susceptibility among day care workers is probably low. Immunocompromised children can be vaccinated or given varicella-zoster immune globulin (VZIG) after exposure. Questions about the risks of varicella-zoster vaccination (V-Z) concern the production of latent infection and subsequent zoster and the effect on the epidemiology of infection, i.e., its possible delay until adulthood. Zoster has been found not to be more frequent in immunized than in nonimmunized leukemic children, and normal vaccinees retain good antibody titers five years after vaccination and have titers similar to individuals who have had varicella 10 years after vaccination. Vaccine efficacy is excellent, but its desirability will be determined after resolution of questions concerning the long-term impact of its use.",
author = "Brunell, {P. A.} and Wiedeman, {Jean A} and Lievens, {A. W.}",
year = "1986",
month = "7",
language = "English (US)",
volume = "8",
pages = "589--590",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Varicella in day care centers.

AU - Brunell, P. A.

AU - Wiedeman, Jean A

AU - Lievens, A. W.

PY - 1986/7

Y1 - 1986/7

N2 - Spread of varicella in day care is controlled by excluding children at the first signs of illness. Exclusion is generally ineffective. Minimally ill children might be permitted to attend day care. This approach may lead to exposure of those in high-risk groups, i.e., adults or immunocompromised children. Morbidity is greater in adults, but susceptibility among day care workers is probably low. Immunocompromised children can be vaccinated or given varicella-zoster immune globulin (VZIG) after exposure. Questions about the risks of varicella-zoster vaccination (V-Z) concern the production of latent infection and subsequent zoster and the effect on the epidemiology of infection, i.e., its possible delay until adulthood. Zoster has been found not to be more frequent in immunized than in nonimmunized leukemic children, and normal vaccinees retain good antibody titers five years after vaccination and have titers similar to individuals who have had varicella 10 years after vaccination. Vaccine efficacy is excellent, but its desirability will be determined after resolution of questions concerning the long-term impact of its use.

AB - Spread of varicella in day care is controlled by excluding children at the first signs of illness. Exclusion is generally ineffective. Minimally ill children might be permitted to attend day care. This approach may lead to exposure of those in high-risk groups, i.e., adults or immunocompromised children. Morbidity is greater in adults, but susceptibility among day care workers is probably low. Immunocompromised children can be vaccinated or given varicella-zoster immune globulin (VZIG) after exposure. Questions about the risks of varicella-zoster vaccination (V-Z) concern the production of latent infection and subsequent zoster and the effect on the epidemiology of infection, i.e., its possible delay until adulthood. Zoster has been found not to be more frequent in immunized than in nonimmunized leukemic children, and normal vaccinees retain good antibody titers five years after vaccination and have titers similar to individuals who have had varicella 10 years after vaccination. Vaccine efficacy is excellent, but its desirability will be determined after resolution of questions concerning the long-term impact of its use.

UR - http://www.scopus.com/inward/record.url?scp=0022745344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022745344&partnerID=8YFLogxK

M3 - Article

C2 - 3018890

AN - SCOPUS:0022745344

VL - 8

SP - 589

EP - 590

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -